Citadel Advisors »

Marker Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Marker Therapeutics (MRKR) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Marker Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Marker Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Marker Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $37k 13k 2.82

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Booking Holdings Call Option (BKNG)
Spdr Gold Tr Gold Shs Call Option (GLD)

View all positions for Citadel Advisors

Top funds holding Marker Therapeutics

NEA Management Company
Aisling Capital Management
Vanguard Group
Geode Capital Management
Renaissance Technologies
Northern Trust
State Street Corporation
Dimensional Fund Advisors
BlackRock
Creative Planning
Matrix Asset Advisors
Citadel Advisors
BlackRock
Advisor Group Holdings
Morgan Stanley

View all funds holding Marker Therapeutics